HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Procter & Gamble Co.


Latest From Procter & Gamble Co.

Sonicare 'Charging Case' Comparison To Oral-B Loses Spark In Ad Review Appeal

Council of Better Business Bureaus appeals board agrees with all but one recommendation NAD made in review of claims for Philips' Sonicare DiamondClean power toothbrush challenged by P&G. In appeal by both firms, panel disagreed with investigative arm on comparative claim about toothbrush travel cases.

OTC Drugs Ad Complaints

C&D Targets Innovation From Revenue Growth On Consumer Health Price Hikes

CEO says higher revenues on consumer health product sales partly due to higher prices should go to innovation rather than advertising. During Q2 earnings briefing, analysts suggest competitors will boost promotions and hamper C&D’s 4% organic growth outlook for 2019.

Sales & Earnings Dietary Supplements

P&G’s Gamble To Hike Prices Pays Off With 4% Net Sales Growth In Q4

For the final quarter of its FY19, P&G reports 4% net sales growth to $17.1bn. Pricing and organic volume each contributed 3 percentage points to organic sales growth in the firm's strongest quarter since before the US financial crisis in 2008.

OTC Drugs Commercial

Teva Divests US OTC Store Brand Portfolio to PL Developments

Israel's Teva has trimmed its OTC portfolio by offloading its US store brands to PL Developments.
United States Health
See All

Company Information